Table 5

 Indicators of diagnostic validity and 95% confidence intervals (CI) of self reported prevalent cancer by tumour site. EPIC-Spain cohort (n = 41238)

n (%)*True positivesFalse negativesFalse positivesSensitivity(CI)Specificity(CI)VPP(CI)VPN(CI)
*Number of confirmed cases and percentage of the total. False negatives  =  another site reported + cancer not reported (in parentheses the number not reporting cancer). False positives  =  another site confirmed + cancer not confirmed (in parentheses the number with non-confirmed cancer).
Breast84 (26.3)7113 (9)15 (13)84.5(75.0 to 91.5)100.0(99.9 to 100.0)82.6(72.9 to 89.9)100.0(100.0 to 100.0)
Oral cavity17 (5.3)413 (9)6 (3)23.5(6.8 to 49.9)100.0(100.0 to 100.0)40.0(12.2 to 73.8)100.0(100.0 to 100.0)
Stomach12 (3.8)66 (3)050.0(21.1 to 78.9)100.0(100.0 to 100.0)100.0(54.1 to 100.0)100.0(100.0 to 100.0)
Colorectal23 (7.2)419 (18)1 (1)17.4(5.0 to 38.8)100.0(100.0 to 100.0)80.0(28.4 to 99.5)100.0(99.9 to 100.0)
Uteri SAI74 (23.1)2351 (46)32 (27)31.1(20.8 to 42.9)99.9(99.9 to 100.0)41.8(28.7 to 55.9)99.9(99.8 to 99.9)
Cervix uteri53 (16.6)746 (33)7 (5)13.2(5.5 to 25.3)100.0(100.0 to 100.0)50.0(23.0 to 77.0)99.9(99.9 to 99.9)
Corpus uteri20 (6.3)317 (13)5 (5)15.0(3.2 to 37.9)100.0(100.0 to 100.0)37.5(8.5 to 75.5)100.0(99.9 to 100.0)
Bladder23 (7.2)518 (17)021.7(7.5 to 43.7)100.0(100.0 to 100.0)100.0(47.8 to 100.0)100.0(99.9 to 100.0)
Thyroid21 (6.6)138 (8)2 (2)61.9(38.4 to 81.9)100.0(100.0 to 100.0)86.7(59.5 to 98.3)100.0(100.0 to 100.0)
Lung8 (2.5)44 (3)3 (2)50.0(15.7 to 84.3)100.0(100.0 to 100.0)57.1(18.4 to 90.1)100.0(100.0 to 100.0)